Find clinical trials for Multiple Myeloma in Portland, OR
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Portland, OR, USA:
of these combinations in participants with relapsed or refractory multiple myeloma. The study will consist of 3 distinct parts: Par ...
Phase 2
Portland, Oregon, United States and 40 other locations
of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...
Phase 3
Portland, Oregon, United States and 59 other locations
of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple...
Phase 2
Portland, Oregon, United States and 51 other locations
antibody (mAb). Renal impairment is a major complication of multiple myeloma (MM) and the majority of MM participants is either at ...
Phase 1
Portland, Oregon, United States and 18 other locations
A Phase II study of anitocabtagene-autoleucel (formerly CART-ddBCMA) for patients with relapsed or refractory multiple myeloma. Ani...
Phase 2
Portland, Oregon, United States and 19 other locations
with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...
Phase 3
Portland, Oregon, United States and 285 other locations
receiving 6 cycles of study treatment. Minimal residual disease is multiple myeloma cells below the level of 1 cancer cell out of 1...
Phase 2
Portland, Oregon, United States and 9 other locations
the study treatment (Part 2) and to evaluate the anticancer activity of talquetamab + teclistamab in participants with relapsed or refractory multiple...
Phase 1, Phase 2
Portland, Oregon, United States and 39 other locations
Researchers want to learn if MK-4002 (also known as HPN217) can treat relapsed or refractory multiple myeloma (RRMM). The goals of ...
Phase 1
Portland, Oregon, United States and 12 other locations
find out what is the best dose of REGN5458 to give to patients with multiple myeloma. An additional purpose is to look for any sign...
Phase 1, Phase 2
Portland, Oregon, United States and 41 other locations
Clinical trials
Research sites
Resources
Legal